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Abstract Three novel human sequences showing striking
homology to the recently described bovine Ca2+/calmodulin
kinase II-dependent epithelial chloride channel bCaCC have been
identified in an expressed sequence tags database. Full-length
clones were isolated using a 5P RACE approach. The encoded
predicted proteins display 65% overall homology to bCaCC.
Tissue expression patterns of the corresponding genes, desig-
nated as hCaCC-1, -2 and -3, appear to be highly restricted, with
the first two genes primarily expressed in the digestive tract.
Another original feature as compared to the CaCC family
members is the fact that hCaCC-2 also shows expression in the
brain. Taken together these findings demonstrate the existence of
several CaCC-like genes in humans, some of which display
distinct tissue specificity patterns within the CaCC subfamily of
chloride channels.
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1. Introduction
Chloride channels form a large functional family with struc-
turally diverse members, from neuronal ligand-gated channels
such as GABAA and glycine receptors, to the CLC family of
voltage-dependent channels found in a variety of tissues. Pe-
ripheral chloride channels are involved in the regulation of
electrolytic £uxes, thereby modulating secretion, absorption,
cell volume and membrane potential. These channels have
received much attention since the discovery of an impaired
chloride permeability in cystic ¢brosis, the most common hu-
man fatal genetic disease. Genetic linkage studies and posi-
tional cloning eventually lead to the identi¢cation of the trans-
membrane conductance regulator (CFTR) gene, which was
subsequently characterized as a cAMP-regulated chloride
channel structurally related to the family of the ATP binding
cassette transporters (for a review on CFTR, see [1]). Since
then, other human diseases have also been found to result
from mutations in chloride channels: Dent’s disease, X-linked
nephrolithiasis and X-linked recessive phosphataemic rickets
with ClC-5 [2], and autosomal dominant myotonia congenita
and autosomal recessive general myotonia with ClC-1 [3^6].
In a search for respiratory epithelium calcium-regulated chlo-
ride channels, a new channel was a⁄nity-puri¢ed from bovine
tracheal apical membrane vesicules and biochemically charac-
terized as a 140 kDa complex [7]. According to electrophysio-
logical studies on reconstituted planar lipid bilayers including
the puri¢ed protein, this protein behaves as an anion selective
channel [8]. This channel would be regulated by calcium, via a
calmodulin kinase II-dependent mechanism [9]. Cloning and
sequencing of the encoding gene, bCaCC, indicated that this
protein is unrelated to previously described chloride channels,
and that its expression would seem to be restricted to the
trachea [10]. An outwardly rectifying DIDS-sensitive anion
conductance was detected in bCaCC-sense cRNA injected
Xenopus oocytes. Similarly, a Ca2-dependent anion conduct-
ance was observed in COS-7 cells transfected with a CaCC-
encoding plasmid [10]. A related gene, Lu-ECAM, has been
cloned from the bovine aortic endothelial cell line BAEC [11].
This gene is expressed in the lung and spleen but not in the
trachea as assessed using RT-PCR. The family considerably
enlarged by the end of 1998, with the publication of two addi-
tional bCaCC homologs, the mouse mCLCA1 [12] and the
human hCLCA1 [13]. Both were shown to generate Ca2-de-
pendent chloride currents upon transfection in HEK293 cells.
In a search for human homologs of the bovine Ca2/cal-
modulin kinase II-dependent epithelial chloride channel, we
have identi¢ed and cloned three human cDNAs bearing
V65% homology with bCaCC at the protein level. One of
these eventually proved to be identical to hCLCA1. In this
report, we present evidence that these genes form a family
along with bovine CaCC, Lu-ECAM and mCLCA1. Previ-
ously reported bCaCC-related genes are mainly expressed in
the respiratory epithelia. One of the human CaCC-like genes
that we isolated is also primarily expressed in the trachea, but
the other two display an original tissue distribution, with
preferential transcription in the intestine.
2. Materials and methods
2.1. Sequencing
All DNA sequencing was performed by Genome Express (Greno-
ble, France).
2.2. Basic molecular biology techniques
Basic molecular biology techniques are described in Maniatis et al.
[14].
2.3. Homology search and sequence analysis
Human Genome Sciences Expressed Sequence Tags database was
screened with the published bovine CaCC protein sequence (SWISS-
PROT P54281) using the Blast program [15]. Three clones, HSIAL89,
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HAGDH75 and HWHPE04, were identi¢ed as new human homologs,
retrieved and sequenced. Clone HSIAL89 contained a 2366 bp cDNA
insert cloned in the EcoRI-XhoI sites of pBluescript SK3 vector;
HAGDH75 contained a 1473 bp cDNA insert cloned as the HSIAL89
insert, and HWHPE04 contained a 2912 bp cDNA inserted in SalI-
NotI sites of pCMVSport3.0 vector (LifeTechnologies). The genes
encoding HSIAL89, HAGDH75 and HWHPE04 cDNAs were named
hCaCC-1, hCaCC-2 and hCaCC-3, respectively. Basic nucleotide se-
quence analysis was performed using the Lasergene software (DNAs-
tar). Signal peptide prediction was performed using G. von Heijne
algorithm [16]. CaCC-related sequences were retrieved from GenBank
database (accession numbers: bCaCC U36445; Lu-ECAM
AF001261; mCLCA1 AF052746; gob-5 AB017156; hCLCA1
AF039400). Protein sequences from members of the CFTR, CLC,
glycine receptor and GABA-A receptor families were retrieved from
the SWISS-PROT database. Protein sequence alignments were per-
formed using CLUSTAL_W [17]. The phylogenetic tree was built
following the neighbor-joining method with PHYLO_WIN [18].
2.4. hCaCC-1 and hCaCC-2 full-length cDNA cloning
HCaCC-1 and hCaCC-2 ORF 5P ends were generated using the
rapid ampli¢cation of cDNA ends (RACE) technique [19]. Two re-
actions were always run in parallel and subclones derived from them
were sequenced in order to ensure the absence of mutations possibly
introduced by polymerase chain reaction (PCR). Chameleon cDNA
(0.5 ng) derived from human colon was ampli¢ed using the manufac-
turer’s speci¢cations (Clontech) with the following modi¢cations:
2.8 U expand polymerase (Boehringer Mannheim) was used in reac-
tion bu¡er containing 0.2 WM primers. Cycling conditions were: 94‡C
30 s, (94‡C 5 s; 72‡C 4 min) 3 cycles, (94‡C 5 s; 70‡C 4 min) 3 cycles,
(94‡C 5 s; 68‡C 4 min) 20 cycles, 68‡C 10 min, using a Perkin Elmer
2400 thermocycler. One twentieth of the RACE product was ampli¢ed
again under the same conditions using nested primers and the second-
ary PCR product was directly cloned into the TOPO cloning vector
(InVitrogen). (1) hCaCC-1 : Four clones containing the longest inserts
(0.8 kb) were sequenced. These clones contained an ATG initiation
codon near the 5P end that was in-frame with HSIAL89 ORF, as
assessed by alignment of the deduced protein sequences with
HSIAL89 putative protein product. sscDNA was then synthesized
from 50 ng human colon poly(A)+ RNA (Clontech) using superscript
reverse transcriptase II according to the speci¢cations of the manu-
facturer (Life Technologies). A PCR ampli¢cation was conducted on
1/10th of the sscDNA, using Pfu Turbo polymerase (2.5 U, Strata-
gene), and two hCaCC-1-speci¢c primers designed to generate the
same 800 bp fragment as obtained in the original RACE. Cycling
was performed in a Perkin Elmer 2400 thermocycler as follows:
94‡C 1 min, (94‡C 10 s; 57‡C 20 s; 72‡C 4 min) 30 cycles, 72‡C
15 min. A full-length hCaCC-1 cDNA was constructed by subcloning
the PCR fragment in-frame with the insert of the HSIAL89 plasmid,
taking advantage of the presence of a unique EcoRI site in the over-
lapping region between the PCR fragment and the plasmid insert.
Full-length recombinant clones were selected based on their restriction
digestion pattern. Four clones were partially sequenced and found to
be identical. The insert of one of these clones was then entirely se-
quenced. (2) hCaCC-2 : The cloning strategy used to generate a full-
length hCaCC-2 cDNA was essentially the same as that described
above, except for the following: RACE PCR product was 1.8 kb
long; Pfu ampli¢cation cycling conditions were: 94‡C 1 min, (94‡C
10 s; 72‡C 4 min) 30 cycles, 72‡C 15 min; the Pfu PCR product was
inserted in-frame of the insert of the HAGDH75 plasmid using a
unique BsmI restriction site in the overlapping region between the
PCR fragment and the plasmid insert.
2.5. Northern and dot blot hybridizations
HSIAL89 AvaI 1.7 kb fragment, HAGDH75 EcoRI-XhoI 1.6 kb
fragment, HWHPE04 HindIII 1.65 kb fragment and glyceraldehyde-3-
phosphate-dehydrogenase cDNA fragment (Clontech) were radiola-
beled by random priming [20] using K32P-dCTP (NEN) and the Meg-
aprime labeling kit (Amersham). Multiple tissue Northern blots, con-
taining 2 Wg poly(A)+ RNA per lane from a variety of human tissues,
and Master dot blots, containing poly(A)+ from 50 human tissues in
such quantities as to obtain similar hybridization signal intensities in
the various tissues with a panel of 8 housekeeping genes (Clontech),
were hybridized overnight in ExpressHyb (Clontech) hybridization
solution at 68‡C (MTN) or 65‡C (dot blots) and washed to a ¢nal
stringency of 0.1USSC, 0.1% SDS, 50‡C (MTN) and 0.1USSC, 0.5%
SDS, 50‡C (Master). All steps were performed according to the spec-
i¢cations of the manufacturers. The hybridization signals were de-
tected using a Storm 860 apparatus and quanti¢ed using Image-
QuaNT software (Molecular Dynamics).
3. Results
3.1. Identi¢cation of CaCC-related genes and full-length
cloning
Using a homology search approach, we identi¢ed three new
human sequences in a proprietary EST database that dis-
played signi¢cant homology with the bovine Ca2/calmodulin
kinase II-dependent epithelial chloride channel bCaCC. This
¢nding was con¢rmed upon sequencing of the entire cDNA of
the corresponding clones, which displayed V65% overall ho-
mology with bCaCC at the protein level. The genes encoding
these sequences were therefore named hCaCC-1, hCaCC-2
and hCaCC-3, respectively. Based on ORF prediction and
alignment with bCaCC protein sequence, the 2.9 kb insert
of hCaCC-3 appeared to encode a full-length protein, whereas
hCaCC-1 and hCaCC-2 clones appeared to contain incom-
plete cDNAs at the 5P end, missing at least 465 bp and
1770 bp, respectively. hCaCC-1 and hCaCC-2 5P coding se-
quences were generated using a RACE approach, and the full-
length cDNAs were obtained by in-frame insertion of the
missing fragments in the original clone using restriction diges-
tion. Reconstructed full-length hCaCC-1 cDNA was 2.8 kb
Fig. 1. Phylogenetic tree of chloride channels. A phylogenetic tree
was built based on the deduced sequences of the putative protein
products of bCaCC and related genes as well as on the protein se-
quences of various members of the CFTR, CLC, glycine receptor
and GABAA receptor chloride channel subfamilies. Scale bar repre-
sents 10% diversity.
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Fig. 2. Protein sequence alignment of hCaCC-1, -2 and -3 with bCaCC-related sequences. Conserved residues are highlighted by black boxes.
Residues are numbered according to their position in the sequence.
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long, whereas hCaCC-2 cDNA was 3.3 kb long. The sizes
of the predicted hCaCC-1, hCaCC-2 and hCaCC-3 protein
products, 914 amino acids (aa), 917 aa and 943 aa, respec-
tively, were similar to that of the bovine CaCC, a 903 aa
polypeptide. All three putative proteins were predicted to
have a signal peptide, similarly to the bCaCC (data not
shown).
3.2. Homology between the CaCC family members
All three human predicted protein sequences display a sim-
ilar degree of overall homology with bCaCC putative protein
product: 51% to 54% identity and 65% to 68% similarity.
Amongst the human proteins, hCaCC-1 and hCaCC-2 ap-
peared to be closer, with a global 62% identity and 74% sim-
ilarity. hCaCC-3 showed only 45% identity and 63% similarity
to hCaCC-1 and -2. Using multiple protein sequence align-
ment algorithms, the three human predicted protein sequences
were compared with bCaCC, Lu-ECAM, mCLCA1,
hCLCA1, as well as to a variety of chloride channels such
as CFTR, ClCs and GABAA receptors, included as reference
chloride channel family members. hCLCA1, a very recently
published human bCaCC-like sequence [13], was included in
this analysis, as well as mouse gob-5 sequence [21], which we
found to be a new CaCC-related sequence in a routine ho-
mology search of public databases. The resulting phylogenetic
tree clearly shows that hCaCC-1 and hCLCA1 are identical,
and that hCaCC-1/hCLCA1, hCaCC-2 and hCaCC-3 form a
subfamily together with bCaCC, Lu-ECAM, mCLCA1 and
gob-5 (Fig. 1). This tree also illustrates how structurally dis-
tant chloride channel subfamilies are from each other. Within
the CaCC family, mCLCA1 appears to be closer to bCaCC
and Lu-ECAM, whereas gob-5 is mostly related to hCaCC-1,
suggesting that it may encode the murine homolog of this
human gene. Examination of the sequence alignment of the
bCaCC-related proteins (Fig. 2) reveals signi¢cant conserva-
tion level throughout the entire sequences, with the exception
of the N- and C-termini. Some regions are particularly well
conserved, forming sequence motifs that may have signi¢-
cance at the structural or the functional level. The most con-
served region, from residue 153 to residue 169 of bCaCC,
contains an HEXXH motif. Such a motif is found in a num-
ber of metal binding proteins, where it forms part of the metal
atom binding site. In a number of families, X-ray analysis
indicated that the two H residues of the motif are involved
in Zn2 binding, together with another E or H, located in the
next 50 residues [22]. Interestingly, a conserved E is found in
the next 10 residues of the HEXXH motif of all CaCC-related
sequences.
3.3. Tissue distribution of the hCaCCs
3.3.1. General. The tissue distribution of these new genes
was determined using Northern analysis (Fig. 3) as well as
RNA dot blot hybridization (Fig. 4). Using an hCaCC-1-de-
rived probe, a unique 2.9 kb band was detected, whereas
hCaCC-2 and hCaCC-3 probes revealed 3.5 kb and 4.2 kb
bands, respectively. These transcript sizes are similar to that
of bCaCC, which is 3.1 kb. An additional minor 8.0 kb band
was also detectable in the brain with the hCaCC-2 probe.
Northern blot experiments suggested that the expression of
these three genes would be spatially restricted. Indeed, no
signal was found in organs such as heart, lung, liver, kidney
or pancreas (Fig. 3). This ¢nding was con¢rmed on the RNA
dot blots, which are optimized for the comparison of gene
expression between 50 di¡erent human tissues (Fig. 4).
3.3.2. hCaCC-1. Quanti¢cation of the hybridization sig-
nals obtained with an hCaCC-1 probe on the RNA dot blot
indicated that hCaCC-1 mRNA was essentially present in the
digestive tract. Highest expression was found in the colon,
small intestine and appendix. Hybridization signal intensities
were quite high in these tissues, suggesting that the transcript
would be rather abundant in the intestine. These ¢ndings were
in good agreement with the fact that most hCaCC-1 ESTs
found in databases originated from sequencing of small intes-
tine- and colon-derived cDNA libraries. There was also a
good correlation with the Northern blot data, where an in-
tense band was seen in small intestine and colon. Expression
of hCaCC-1 was also assessed in a fourth region of the diges-
tive tract, the stomach. A very low signal was detectable on
both types of blots. Quanti¢cation on the RNA dot blot in-
dicated that hCaCC-1 expression in this tissue would be about
100 times lower than that detected in colon.
Three other adult tissues were labeled on the RNA dot blot,
indicating that expression of hCaCC-1 gene is not strictly
restricted to the digestive tract. These tissues, namely uterus,
testis and kidney, belong to the urogenital tract. Signal inten-
sities were very low, about 2 to 3 orders of magnitude below
Fig. 3. Northern analysis of hCaCC-1, -2 and -3 tissue distribution.
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that of colon. In addition, a very faint spot was detected in
the prostate poly(A)+ dot, that could not be quanti¢ed and
therefore does not appear on the histogram Fig. 4. Expression
in this gland was con¢rmed on the Northern blot (Fig. 3). The
correlation between the Northern and the RNA dot blot data
was not as good for the very low level signals as for the
intense ones, as no band could be detected either in uterus
or kidney on the Northern blot. More generally, low level
signals, below 10 000 arbitrary units, are to be interpreted
with caution and would need to be con¢rmed using a di¡erent
approach. In fetal tissues, hCaCC-1 probe labeled a unique
dot, corresponding to spleen.
3.3.3. hCaCC-2. Similarly to the hCaCC-1 probe, the
hCaCC-2-derived probe labeled colon poly(A)+ RNA to the
highest extent in RNA dot blot hybridizations. However, its
labeling pattern within the digestive tract tissues was consid-
erably di¡erent. Small intestine, appendix and stomach signals
were among the weakest, about 50 to 100 times lower than
that of colon. The second major signal was observed in tra-
chea. It was estimated to be about 10 times less intense than
the signal detected in colon. A number of other minor but
signi¢cant spots were detected in a variety of tissues such as
brain and the urogenital organs, bladder, prostate and uterus.
Weak spots were also observed in the testis, as well as salivary
and mammary glands. These ¢ndings were in good agreement
with the Northern data, when assessable, except for the fact
that no signal was observed in the uterus sample. On the
Northern, the size of the band that was observed in the
poly(A)+ from the small intestine appeared to be lower than
in the other tissues. This band would possibly correspond to
an alternative transcript or to limited cross-hybridization with
hCaCC-1 mRNA, although this second hypothesis would
seem unlikely given the low level of conservation between
the two sequences. According to the RNA dot blot analysis,
expression in the brain would seem to be rather uniform,
apart from cerebellum where no signal was detected. These
data were con¢rmed on Northern blots containing poly(A)+
RNA from the same 15 brain regions that are present on the
RNA dot blot. The same two 3.5 kb and 8 kb bands seen in
the whole brain sample of the Northern blot shown in Fig. 3
were detected with similar intensities in all brain regions, ex-
cept for the cerebellum where it was notably fainter (data not
shown).
3.3.4. hCaCC-3. The tissue distribution of hCaCC-3 was
analyzed by hybridizing an RNA dot blot with a hCaCC-3-
derived cDNA probe. The main signal was observed in the
trachea (Fig. 4) whereas very faint spots were detectable in
uterus, prostate, testis and kidney. On Northern blots, the
Fig. 4. RNA dot blot analysis of hCaCC-1, -2 and -3 tissue distribution. Hybridization signal intensities are expressed as arbitrary units and
displayed using a log scale.
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hCaCC-3 probe revealed a 4.2 kb band in bladder, stomach
and prostate, whereas no signal could be seen in uterus or
kidney.
4. Discussion
We have identi¢ed and isolated three new human genes,
which are related to the bovine Ca2/calmodulin kinase II-
activated epithelial chloride channel bCaCC [10]. One of
these, namely hCaCC-1, proved to be identical to hCLCA1,
a very recently published bCaCC-related chloride channel
[13]. The degree of sequence conservation between these hu-
man genes and the bovine CaCC, about 65% at the protein
level, would suggest that they form a structural subfamily.
This new protein subfamily seems to be conserved not only
between man and bovine, but also in rodents as a bCaCC
homolog, mCLCA1, showing 80% homology at the protein
level was recently described in the mouse [12]. In addition, we
have found that the mouse gob-5 gene, whose sequence was
recently deposited in public databases [21], is a close homolog
of hCaCC-1. However, hCaCC-1, -2 or -3 would not seem to
encode a human counterpart of bCaCC, as if so, the degree of
homology would be expected to be at least 80%. Therefore, a
fourth human CaCC sequence most probably remains to be
identi¢ed. The existence of CaCC-related genes in several
mammalian species would suggest that the biological function
of this family of proteins was evolutionarily conserved. How-
ever, no CaCC type sequence could be found in yeast genome
using a homology search approach, suggesting that this family
emerged after or with the metazoans.
One of the most impressive features of these new human
genes is their expression pattern. One of these genes, hCaCC-
3, is expressed in the trachea. Noteworthy, Ca2-stimulated
chloride channels, presently unidenti¢ed, have been reported
in the apical membrane of human airway epithelia. These
channels, that are not a¡ected in cystic ¢brosis patients [23],
may represent potential therapeutic targets to treat this dis-
ease. Such a hypothesis is based on the ¢nding that an up-
regulation of Ca2-activated Cl3 £uxes takes place in the
nasal epithelium of knock-out cftr3=3 mice, and accounts
for the absence of any signi¢cant pathology in these model
animals [24,25]. Given their relatedness to the Ca2-activated
chloride channel bCaCC and their transcription in human
trachea, it is tempting to speculate that hCaCC-2 and
hCaCC-3 might be encoding such channels.
Besides, although tissue distribution of hCaCC-3 is some-
what reminiscent of that of bCaCC as it is mainly expressed in
the trachea, hCaCC-1 and hCaCC-2 present an expression
pattern that is unique compared to that of Lu-ECAM,
bCaCC and mCLCA1. hCaCC-1 transcription is strikingly
associated with the digestive tract. Among 50 di¡erent human
tissues, very few structures other than those belonging to the
digestive tract were found to express this gene, and always at
a very low level compared to the intestine. Within the diges-
tive tract, hCaCC-1 mRNA distribution was not uniform,
with strikingly higher expression in small intestine, colon
and appendix compared to stomach. These ¢ndings are in
good agreement with the previously reported tissue distribu-
tion of hCLCA1 which was described by Gruber et al. (1998)
as speci¢cally expressed in the colon and small intestine based
on the Northern blot technique and on in situ hybridization
[13]. hCaCC-2, the second new human gene that we identi¢ed,
is more widely distributed. However, its expression is prom-
inent in the colon, with only minor expression in the other
tissues tested. Contrary to hCaCC-1, hCaCC-2 is only weakly
expressed in the small intestine and appendix, indicating that
the expression of these two homologous human genes would
be regulated independently in the gut.
Expression of hCaCC-1 and hCaCC-2 in the intestine is
very interesting with respect to their potential Ca2-dependent
chloride channel function. Indeed, chloride channels play an
important role in the regulation of water and electrolytic
£uxes in the intestinal epithelium. Both cAMP- and Ca2-
dependent Cl3 currents have been described in animal intes-
tinal epithelial cells, as well as in human and rodent colon-
derived cell lines [26^29]. A Ca2/calmodulin kinase II-de-
pendent Cl3 current, reminiscent of the bCaCC type, has
been reported in the T84 colonic tumoral cell line [30,31].
However, Anderson and Welsh [32,33] reported that there
are no Ca2-dependent but only cAMP-dependent Cl3 chan-
nels at the apical surface of intestinal mucosa, a crucial issue
with respect to the potential biological role of these channels
in the intestine. Indeed, apical Cl3 channels would regulate
£uid and electrolyte transport in secretory epithelia according
to the current hypothesis. Localizing hCaCC-1 and -2 proteins
within the digestive wall, together with assessment of their
putative chloride channel function, would be of primary in-
terest in this controversy.
Another most interesting characteristic of hCaCC-2 expres-
sion is its transcription in the brain, a unique feature among
the bCaCC family. Ca2-dependent chloride channels have
been characterized in olfactory sensory neurons, where they
would play a role in odor detection [34,35], and they have also
been described in microglia [36], but to our knowledge there is
no evidence to date of a Ca2/calmodulin kinase II-dependent
channel in the brain. Therefore, in order to better understand
the potential role of hCaCC-2 in this organ, it would be in-
teresting to determine its cell type speci¢city in the central
nervous system.
An intriguing question about the hCaCCs, and more gen-
erally about all new bCaCC-related genes is their biological
function. Indeed, although bCaCC and more recently
mCLCA1 and hCLCA1 were characterized as Ca2-dependent
chloride channels, the close homolog Lu-ECAM was identi-
¢ed as an adhesion molecule, mediating adhesion of tumor
cells to lung epithelium [37]. Evidence that bCaCC, mCLCA1
and hCLCA1 encode chloride channels is based on electro-
physiological studies on bCaCC cRNA injected Xenopus oo-
cytes, as well as on bCaCC, mCLCA1 and hCLCA1 transi-
ently transfected mammalian cells [10,12,13]. The possibility
remains that the observed currents were not directly associ-
ated with the expression of the various bCaCC family mem-
bers, but were rather due to activation of an endogenous
channel by an indirect mechanism, as suggested for pI(Cln)
[38]. Such a hypothesis would suggest that expressed bCaCC
might in fact play the role of a regulatory protein required for
the activation of endogenous chloride channels. Conversely,
multifunctional proteins are well known, and it is also con-
ceivable that a channel that is present at the cell surface might
also serve as an adhesion molecule in some conditions. Such a
protein with a double function associating a channel activity
to an adhesion function has previously been described in C.
elegans, where the unc-105 gene encodes an epithelial Na
channel of the degenerin family that interacts with type IV
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collagen [39]. Clearly, one of the major directions for further
investigations concerning the hCaCC proteins is the character-
ization of their in vivo biological functions.
Acknowledgements: The authors are thankful to H. Esnaud for excel-
lent technical support. They are particularly grateful to M. Partiseti
and B. Cornet for their suggestions and support to the project, and to
D. Graham, J. Goldhill and Y. Lopez for helpful discussions.
References
[1] Jilling, T. and Kirk, K.L. (1997) Int. Rev. Cytol. 172, 193^241.
[2] Fisher, S.E., Black, G.C., Lloyd, S.E., Hatchwell, E., Wrong, O.,
Thakker, R.V. and Craig, I.W. (1994) Hum. Mol. Genet. 3,
2053^2059.
[3] Koch, M.C., Steinmeyer, K., Lorenz, C., Ricker, K., Wolf, F.,
Otto, M., Zoll, B., Lehman-Horn, F., Grzeschik, K.-H. and
Jentsch, T.J. (1992) Science 257, 797^800.
[4] George, A.L.J., Crackover, M.A., Abdalla, J.A., Hudson, A.J.
and Ebers, G.C. (1993) Nat. Genet. 3, 305^310.
[5] Steinmeyer, K., Lorenz, C., Pusch, M., Koch, M.C. and Jentsch,
T.J. (1994) EMBO J. 13, 737^743.
[6] Lorenz, C., Meyer-Kleine, C., Steinmeyer, K., Koch, M.C. and
Jentsch, T.J. (1994) Hum. Mol. Genet. 3, 941^946.
[7] Ran, S. and Benos, D.J. (1992) J. Biol. Chem. 267 (6), 3618^
3625.
[8] Ran, S., Fuller, C.M., Pia Arrate, M., Latorre, R. and Benos,
D.J. (1992) J. Biol. Chem. 267, 20630^20637.
[9] Fuller, C.M., Ismailov, I.I., Keeton, D.A. and Benos, D.J. (1994)
J. Biol. Chem. 269 (43), 26642^26650.
[10] Cunningham, S.A., Awayda, M.S., Bubien, J.K., Ismailov, I.I.,
Pia Arrate, M., Berdiev, B.K., Benos, D.J. and Fuller, C.M.
(1995) J. Biol. Chem. 270 (52), 31016^31026.
[11] Elble, R.C., Widon, J., Gruber, A.D., Abdel-Ghany, M., Levine,
R., Goodwin, A., Cheng, H.-C. and Pauli, B.U. (1997) J. Biol.
Chem. 272 (44), 27853^27861.
[12] Gandhi, R., Elble, R.C., Gruber, A.D., Schreur, K.D., Ji, H.-L.,
Fuller, C.M. and Pauli, B.U. (1998) J. Biol. Chem. 273 (48),
32096^32101.
[13] Gruber, A.D., Elble, R.C., Ji, H.-L., Schreur, K.D., Fuller, C.M.
and Pauli, B.U. (1998) Genomics 54 (2), 200^214.
[14] Sambrook, J., Fritzch, E.F. and Maniatis, T. (1982) Molecular
Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY.
[15] Altschul, S.F., Madden, T.L., Scha¡er, A.A., Zhang, J., Zhang,
Z., Miller, W. and Lipman, D.J. (1997) Nucleic Acids Res. 25,
3389^3402.
[16] von Heijne, G. (1986) Nucleic Acids Res. 14, 4663^4690.
[17] Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) Nucleic
Acids Res. 22, 4673^4680.
[18] Galtier, N., Gouy, M. and Gautier, C. (1996) Comput. Appl.
Biosci. 12, 543^548.
[19] Frohman, M.A., Dush, M.K. and Martin, G.R. (1988) Proc.
Natl. Acad. Sci. USA 85, 8998^9002.
[20] Feinberg, A.P. and Vogelstein, B. (1983) Anal. Biochem. 132, 6^
13.
[21] Komiya, T., Tanigawa, Y. and Hirohashi, S. (1998) Cloning of a
gene, gob-5, which is expressed in intestinal goblet cells in mice,
unpublished. Sequence submitted to GenBank.
[22] Rawlings, N.D. and Barrett, A.J. (1995) Methods Enzymol. 248,
183^228.
[23] Frizzell, R.A., Rechkemmer, G. and Shoemaker, R.L. (1986)
Science 233, 558^560.
[24] Clarke, L.L., Grubb, B.R., Ynakaskas, J.R., Cotton, C.U.,
McKenzie, A. and Boucher, R.C. (1994) Proc. Natl. Acad. Sci.
USA 91, 479^483.
[25] Grubb, B.R., Vick, R.N. and Boucher, R.C. (1994) Am. J. Phys-
iol. 266, C1478^C1483.
[26] Frizzell, R.A., Halm, D.R., Rechkemmer, G. and Shoemaker,
R.L. (1986) FASEB J. 45 (12), 2727^2731.
[27] Cli¡, W.H. and Frizzell, R.A. (1990) Proc. Natl. Acad. Sci. USA
87, 4956^4960.
[28] Vaandrager, A.B., Bajnath, R., Groot, J.A., Bot, A.G.M. and
DeJonge, H.R. (1991) Am. J. Physiol. 261, G958^G965.
[29] Sahi, J., Wiggins, M.P., Gibori, G.B., Layden, T.J. and Rao,
M.C. (1996) J. Cell Physiol. 168 (2), 276^283.
[30] Worrell, R.T. and Frizzell, R.A. (1991) Am. J. Physiol. 260,
C877^C882.
[31] Arreola, J., Melvin, J.E. and Begenisich, T. (1998) Am. J. Phys-
iol. 274, C161^C166.
[32] Anderson, M.P. and Welsh, M.J. (1991) Proc. Natl. Acad. Sci.
USA 88, 6003^6007.
[33] Anderson, M.P., Sheppard, D.N., Berger, H.A. and Welsh, M.J.
(1992) Am. J. Physiol. 263, L1^L14.
[34] Reuter, D., Zierold, K., Schroder, W.H. and Frings, S. (1998)
J. Neurosci. 18 (17), 6623^6630.
[35] Hallani, M. and Lynch, J.W. (1998) J. Membr. Biol. 161 (2),
163^171.
[36] Eder, C. (1998) Am. J. Physiol. 275, C327^C342.
[37] Zhu, D., Cheng, C.F. and Pauli, B.U. (1991) Proc. Natl. Acad.
Sci. USA 88, 9568^9572.
[38] Krapivinsky, G., Ackerman, M., Gordon, E., Krapivinsky, L.
and Clapham, D.E. (1994) Cell 76, 439^448.
[39] Liu, J., Schrank, B. and Waterston, R.H. (1996) Science 273,
361^364.
FEBS 22341 16-7-99
M. Agnel et al./FEBS Letters 455 (1999) 295^301 301
